Skip to content

Evidence Explorer · EV-004

TEMPO participants

FDA currently lists Cadence Solutions' HypertensionOS and Dexcom's Glucose Health Program in TEMPO.

E5100/100 confidenceFederal participant table

What this evidence supports

FDA's TEMPO table currently lists Cadence Solutions and Dexcom.

What it does not establish

Participant list is dynamic; intended uses remain under evaluation.

Record details

Source authority: FDA
Evidence level: E5
Directness: 5/5
Recency: 5/5
Decision relevance: 5/5
Date: 2026-08-08

Primary source

https://www.fda.gov/medical-devices/digital-health-center-excellence/participants-selected-tempo-digital-health-devices-pilot

Related intelligence

FDA TEMPO participant page now lists Cadence Solutions and Dexcom